Health Care Venture Capital: Funding Advances in Treatment
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Health Care Venture Capital: Funding Advances in Treatment
InterWest's health care team invests venture capital in a variety of companies; funding therapeutics, diagnostics and devices. We are known for investing in early-stage companies that go on to achieve substantial success, including such investments as Aspreva, Epocrates and IntraLase.
At InterWest, providing venture capital to health care companies is just the beginning of an ongoing relationship in which we combine funding with a deep understanding of the markets in which we invest. We are proud that our team of investment professionals includes executives from past portfolio companies — and that many of our current portfolio companies are headed by entrepreneurs with whom we have previously invested.
By providing venture capital to a select group of health care innovators we fund the next generation of life sciences advances.














